HSL-IN-3

CAS No. 346656-34-6

HSL-IN-3( Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3 )

Catalog No. M26251 CAS No. 346656-34-6

HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 27 In Stock
10MG 38 In Stock
50MG 50 In Stock
100MG 73 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HSL-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
  • Description
    HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    346656-34-6
  • Formula Weight
    262.11
  • Molecular Formula
    C14H19BO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (381.52 mM)
  • SMILES
    CCOC(=O)c1ccccc1B1OCC(C)(C)CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Snaebjornsson MT, et al. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways. Exp Mol Med. 2018 Apr 16;50(4):34.
molnova catalog
related products
  • Asparagusic acid

    Asparagusic acid is unique to asparagus. It is responsible for the odorous urine excreted after eating asparagus. Its derivatives ihydroasparagusic acid have an anti-inflammatory effect.

  • Pyropheophorbide-a

    Pyropheophorbide-a is a promising photosensitizer for tumor photodynamic therapy (PDT).

  • ICCB280

    ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.